Evidence map›Paper›PMID 42733706›Full record

ReviewBiochemistry and biophysics reports2026

Physical exercise as a therapeutic strategy in animal models of Alzheimer's disease: Molecular, behavioral, and histopathological evidence.

Helia Behrouzfar, Mahdi Gholami, Shokoufeh Hassani, Armin Salek Maghsoudi, Saeed Aghebat Bekheir

Abstract readReview
In one paragraph

Review in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Helia BehrouzfarFaculty of Veterinary Medicine, Science and Research Branch of Islamic Azad University, Tehran, Iran.
Mahdi GholamiDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Shokoufeh HassaniDrug Design and Development Research Center, the Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran.
Armin Salek MaghsoudiToxicology and Disease Group, Pharmaceutical Science and Research Center (PSRC), and Department of toxicology and pharmacology, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Saeed Aghebat BekheirToxicology and Disease Group, Pharmaceutical Science and Research Center (PSRC), and Department of toxicology and pharmacology, Tehran University of Medical Sciences (TUMS), Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Alzheimer's disease (AD) is the most common neurodegenerative disease worldwide, imposing a substantial economic burden. As the population ages and cases rise, interest in early identification, prevention, and treatment has intensified. After establishing that pathology involves neurofibrillary tangles, neuroinflammation, and neuronal loss, interventions have been tested in laboratory animals to slow disease progression. One commonly tested intervention is physical exercise, an economical approach. Laboratory animal models of AD aim to demonstrate how different types and intensities of exercise affect disease pathology. This review aims to categorize and elucidate the mechanisms and their outcomes. Materials and methods: Original manuscripts concerning the impact of exercise, with or without medicinal intervention, on Alzheimer's dementia progression modeled in laboratory animals from 2020 onwards were included. The routes through which exercise exerts its impact at molecular, behavioral, and histomorphological levels were categorized. Results: The most frequent modeling approach was Aβ injection into the hippocampus of Wistar rats, followed by Streptozocin and other chemicals, and transgenic models. Exercise mainly consisted of treadmill or swimming. Interventions were categorized into short-, medium-, and long-term protocols, ranging from 3 to 24 weeks, with most at 4 weeks, 30-60 min per session, 5 days/week. Molecular tests primarily measured Reactive Oxygen Species (ROS), while the most common behavioral test was the Morris Water Maze (MWM), assessing learning and memory. Histopathological assessments focused on β-Amyloid plaque formation, dark cells, and glial activation. Most studies agreed on AD modeling methods, but exercise protocols varied in intensity, duration, and type. The combined use of molecular, behavioral, and histological tests to assess intervention effects was consistent. Conclusion: Physical exercise has been linked to lower oxidative stress and neuroinflammation, enhanced cognitive function, and fewer pathological changes in animal models of AD. However, variability in disease models and exercise protocols makes it difficult to identify the best exercise approach.

Indexed as

Alzheimer'sAnimal modelsDementiaExerciseNeurodegenerativePhysical training

Identifiers

PMID42733706
PMCPMC13571470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.